Stockscreener 앱 받기
0.796
1.23%
-0.0099
시간 외 거래:
.81
0.014
+1.76%
전일 마감가:
$0.8059
열려 있는:
$0.81
하루 거래량:
437.92K
Relative Volume:
0.24
시가총액:
$126.28M
수익:
$3,000
순이익/손실:
$-108.00M
주가수익비율:
-0.5303
EPS:
-1.501
순현금흐름:
$-87.84M
1주 성능:
+0.20%
1개월 성능:
+17.30%
6개월 성능:
-61.91%
1년 성능:
-48.31%
1일 변동 폭
$0.772
$0.81
1주일 범위
$0.76
$0.83
52주 변동 폭
$0.3772
$2.445
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.796 | 127.86M | 3,000 | -108.00M | -87.84M | -1.501 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | 개시 | H.C. Wainwright | Buy |
| 2025-08-28 | 개시 | Ladenburg Thalmann | Buy |
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
모두보기
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
GUTSFractyl Health Inc Options - Finviz
Fractyl Health Price Target Announced at $4.00/Share by Craig-Hallum - Moomoo
GUTS Initiates Coverage by Fractyl Health -- Price Target Set at $4.00 - GuruFocus
Fractyl Health Initiated at Buy by Craig-Hallum - Moomoo
Craig-Hallum initiates Fractyl Health stock coverage with buy rating By Investing.com - Investing.com India
Craig-Hallum initiates Fractyl Health stock coverage with buy rating - Investing.com
Craig-Hallum Initiates Fractyl Health at Buy With $4 Price Target - Moomoo
Fractyl Health, Inc. Actuals & Estimates (NASDAQ:GUTS) - TradingView
GUTS Forecast — Price Target — Prediction for 2027 - TradingView
FRACTYL HEALTH INC (GUTS) Stock Chart - ChartMill
GUTS Q1 2026 Earnings: EPS Beat Amid Pre-Revenue Stage; Stock Declines 4.4%GAAP Earnings Report - Město Břeclav
Fractyl Health Inc (GUTS) Institutional Confidence - TradingKey
Fractyl Health Inc (GUTS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Fractyl Health Inc (GUTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fractyl Health Inc (GUTS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fractyl Health Inc (GUTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fractyl Health Inc (GUTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Fractyl Health director Ajay Royan buys $19,596 in company stock - Investing.com UK
Fractyl Health director Ajay Royan buys $19,596 in company stock By Investing.com - Investing.com UK
Fractyl Health (NASDAQ: GUTS) director adds 23,000 shares in open-market buy - Stock Titan
Fractyl Health, Inc. 8-K Filing June 2026: Company Information, Nasdaq Listing, and Executive Details - Minichart
Fractyl Health Inc (GUTS) Cleared for RJVA-001 Trial. Let’s Look At Funding - Insider Monkey
Fractyl Health director William Bradley buys $50,328 in stock By Investing.com - Investing.com Australia
Fractyl Health director William Bradley buys $50,328 in stock - Investing.com
Fractyl Health (NASDAQ: GUTS) 2026 meeting backs board and auditor - Stock Titan
Fractyl Health (GUTS) director buys stock and receives 22,500 options - Stock Titan
Fractyl Health (GUTS) awards 22,500 stock options to board director - Stock Titan
Fractyl Health (GUTS) awards director 22,500 options at $0.7318 - Stock Titan
Fractyl Health (GUTS) director Marc Elia receives 22,500-share stock option grant - Stock Titan
Fractyl Health (GUTS) director receives 22,500-stock-option board compensation grant - Stock Titan
Director Clive Meanwell gets 22,500 options at Fractyl Health (GUTS) - Stock Titan
Fractyl Health (NASDAQ: GUTS) director buys shares and receives options - Stock Titan
Fractyl Health (GUTS) CEO buys 25,000 open-market shares - Stock Titan
Fractyl Health (GUTS) Surges 10%: Key Levels to Watch After Breakout AttemptPre-Earnings Momentum - dars.gov.et
Fractyl Health CFO Smith Weber Lara purchases $13,708 in stock By Investing.com - Investing.com South Africa
Fractyl Health CFO Smith Weber Lara purchases $13,708 in stock - Investing.com
[Form 4] FRACTYL HEALTH, INC. Insider Trading Activity - Stock Titan
Fractyl Health reports one-year data on weight maintenance therapy - Investing.com UK
GUTS Reiterates by HC Wainwright & Co. -- Price Target Maintained at $8.00 - GuruFocus
Fractyl Health Reports Positive One-Year Results from REVEAL-1 Open-Label Study of Revita Procedure for Post-GLP-1 Weight Maintenance - marketscreener.com
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - markets.businessinsider.com
Fractyl Health Highlights One-Year Revita Obesity Results - TipRanks
Fractyl Health reports one-year data on weight maintenance therapy By Investing.com - Investing.com South Africa
Fractyl Health Reports Positive One-Year Results from REVEAL-1 Cohort, Highlighting Revita's Efficacy in Sustaining Weight Loss Post-GLP-1 Therapy - Quiver Quantitative
Revita study shows durable post-GLP-1 weight loss at Fractyl Health (GUTS) - Stock Titan
Fractyl Health Reports Positive One-Year REVEAL-1 - GlobeNewswire
Fractyl Health Reports Positive One-Year Results from REVEAL-1 Cohort, Highlighting Revita's Efficacy in Sustaining Weight Loss Post-GLP-1 Therapy | GUTS Stock News - Quiver Quantitative
Fractyl Health names Mike Zumdahl as market access head By Investing.com - Investing.com South Africa
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy - The Manila Times
Fractyl Health names Mike Zumdahl as market access head - Investing.com
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fractyl Health Inc 주식 (GUTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BRADLEY WILLIAM | Director |
Jun 10 '26 |
Buy |
0.73 |
68,493 |
50,329 |
84,622 |
| Sheffield Ian | Director |
Jun 10 '26 |
Buy |
0.73 |
35,000 |
25,529 |
35,000 |
| Rajagopalan Harith | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.73 |
25,000 |
18,252 |
540,557 |
| Smith Weber Lara | Chief Financial Officer |
Jun 08 '26 |
Buy |
0.69 |
20,000 |
13,708 |
20,000 |
| Rajagopalan Harith | Chief Executive Officer |
Dec 04 '25 |
Buy |
1.92 |
10,416 |
19,999 |
501,745 |
1.17%
2.48%
자본화:
|
볼륨(24시간):